APA

Zang C., Eucker J., Habbel P., Neumann C., Schulz C., Bangemann N., Kissner L., Riess H. & Liu H. (20160126). Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. : Cell cycle (Georgetown, Tex.).

Chicago

Zang Chuanbing, Eucker Jan, Habbel Piet, Neumann Christian, Schulz Carsten-Oliver, Bangemann Nikola, Kissner Lutz, Riess Hanno and Liu Hongyu. 20160126. Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. : Cell cycle (Georgetown, Tex.).

Harvard

Zang C., Eucker J., Habbel P., Neumann C., Schulz C., Bangemann N., Kissner L., Riess H. and Liu H. (20160126). Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. : Cell cycle (Georgetown, Tex.).

MLA

Zang Chuanbing, Eucker Jan, Habbel Piet, Neumann Christian, Schulz Carsten-Oliver, Bangemann Nikola, Kissner Lutz, Riess Hanno and Liu Hongyu. Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. : Cell cycle (Georgetown, Tex.). 20160126.